CD14 and systemic sclerosis: Trombetta et al. reported that increased rates of circulating pro-inflammatory M1/anti-inflammatory M2 mixed CD14+ monocytes were more associated with systemic sclerosis with interstitial lung diseases than with systemic sclerosis without interstitial lung diseases13.